Ramipril offers hope on peripheral arterial disease
NOTE: THIS RESEARCH HAS BEEN RETRACTED. SEE OUR STORY ON 17 SEPTEMBER 2015.
A LEADING Australian research institute is planning to pursue TGA registration for ramipril as a treatment for claudication in patients with peripheral arterial disease (PAD) after a clinical trial showed it improved walking ability.
The Baker IDI Heart & Diabetes Institute found the generic ACE inhibitor improved maximum